ALVO/ 11/03/2025 · 6:08 AM Alvotech's Biosimilar Drug Faces FDA Setback Due to Manufacturing Issues Alvotech receives FDA complete response letter for AVT05 biosimilar to Simponi, citing manufacturing facility deficiencies. Company revises 2025 revenue outlook downward.